Collegium Pharmaceutical Inc (COLL) — Capital Reinvestment Ratio
Collegium Pharmaceutical Inc (COLL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($78.44 Million) in capital expenditures ($188.00K). See Collegium Pharmaceutical Inc (COLL) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Collegium Pharmaceutical Inc Capital Reinvestment Ratio (2018–2024)
This chart tracks Collegium Pharmaceutical Inc's Capital Reinvestment Ratio across 7 annual periods. Check cash flow reinvestment rate of Collegium Pharmaceutical Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Collegium Pharmaceutical Inc (2018–2024)
Year-by-year Capital Reinvestment Ratio for Collegium Pharmaceutical Inc from 2018 to 2024. For live market cap and broader valuation context, see Collegium Pharmaceutical Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $204.98 Million | $1.65 Million | ▲ +380.3% |
| 2023 | 0.00x | $274.75 Million | $461.00K | ▼ -87.1% |
| 2022 | 0.01x | $124.23 Million | $1.62 Million | ▼ -30.4% |
| 2021 | 0.02x | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 3.98x | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.23x | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.14x | $169.39 Million | $24.35 Million | — |